| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
INVITED REVIEW
1Cardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania; and 2Pacific Northwest Research Institute, and Department of Medicine, University of Washington, Seattle, Washington
A disintegrin and metalloprotease (ADAM) is a membrane-anchored metalloprotease implicated in the ectodomain shedding of cell surface proteins, including the ligands for epidermal growth factor (EGF) receptors (EGFR)/ErbB. It has been well documented that the transactivation of the EGFR plays critical roles for many cellular functions, such as proliferation and migration mediated through multiple G protein-coupled receptors (GPCRs). Recent accumulating evidence has suggested that ADAMs are the key metalloproteases activated by several GPCR agonists to produce a mature EGFR ligand leading to the EGFR transactivation. In this review, we describe the current knowledge on ADAMs implicated in mediating EGFR transactivation. The major focus of the review will be on the possible upstream mechanisms of ADAM activation by GPCRs as well as downstream signal transduction and the pathophysiological significances of ADAM-dependent EGFR transactivation.
ectodomain shedding; angiotensin II
This article has been cited by other articles:
|
|
 |
|
  I. Grimm, N. Messemer, M. Stanke, C. Gachet, and H. Zimmermann Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells J. Cell Sci., July 15, 2009; 122(14): 2524 - 2533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Berasain, M. J. Perugorria, M. U. Latasa, J. Castillo, S. Goni, M. Santamaria, J. Prieto, and M. A. Avila The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer Experimental Biology and Medicine, July 1, 2009; 234(7): 713 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Duffy, E. McKiernan, N. O'Donovan, and P. M. McGowan Role of ADAMs in Cancer Formation and Progression Clin. Cancer Res., February 15, 2009; 15(4): 1140 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yin and F.-S. X. Yu ERK1/2 Mediate Wounding- and G-protein-Coupled Receptor Ligands-Induced EGFR Activation via Regulating ADAM17 and HB-EGF Shedding Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Herrlich, E. Klinman, J. Fu, C. Sadegh, and H. Lodish Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-{beta}, and TGF-{alpha} is specifically triggered by different stimuli and involves different PKC isoenzymes FASEB J, December 1, 2008; 22(12): 4281 - 4295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B.W.H. Melenhorst, G. M. Mulder, Q. Xi, J. G.J. Hoenderop, K. Kimura, S. Eguchi, and H. van Goor Epidermal Growth Factor Receptor Signaling in the Kidney: Key Roles in Physiology and Disease Hypertension, December 1, 2008; 52(6): 987 - 993. [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Block and J. K. Klarlund Wounding Sheets of Epithelial Cells Activates the Epidermal Growth Factor Receptor through Distinct Short- and Long-Range Mechanisms Mol. Biol. Cell, November 1, 2008; 19(11): 4909 - 4917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P-R. Burgel and J. A. Nadel Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Beswick and V. E. Reyes Macrophage Migration Inhibitory Factor and Interleukin-8 Produced by Gastric Epithelial Cells during Helicobacter pylori Exposure Induce Expression and Activation of the Epidermal Growth Factor Receptor Infect. Immun., July 1, 2008; 76(7): 3233 - 3240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Joslin, L. K. Opresko, A. Wells, H. S. Wiley, and D. A. Lauffenburger EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation J. Cell Sci., October 15, 2007; 120(20): 3688 - 3699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, J.-K. Chen, J. R. Falck, S. Anjaiah, J. H. Capdevila, and R. C. Harris Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate Metabolite Mol. Cell. Biol., April 15, 2007; 27(8): 3023 - 3034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells Hypertension, October 1, 2006; 48(4): 534 - 540. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ohtsu, P. J. Dempsey, G. D. Frank, E. Brailoiu, S. Higuchi, H. Suzuki, H. Nakashima, K. Eguchi, and S. Eguchi ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): e133 - e137. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
